| Name | Title | Contact Details |
|---|
PresenceLearning is the leading provider of online special education services for early intervention and K-12 students in the United States. We provide “anytime, anywhere” access to a network of more than 700 fully licensed, highly qualified clinicians who work face-to-face with students via live videoconferencing using our proprietary platform and instructional activities. Since our founding in 2009, we have delivered more than 1,000,000 sessions of teletherapy to hundreds of school districts, charter schools, and virtual school organizations across the United States. And we`re not stopping there. The shortage of Speech-Language Pathologists (SLPs), Occupational Therapists (OTs), and Mental Health Professionals (MHPs) is reaching crisis proportions, innovative modes of delivery have become essential for providing access to therapeutic services. Our dedicated team of employees is committed to seeing children thrive via the growing online therapy revolution.
Renaissance Resource Associate is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biodynamics Engineering is a Pacific Palisades, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
24 Hour Fitness is a privately owned and operated fitness center chain headquartered in San Ramon, California.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.